Improved sensitization of antigen-presenting cells with transferrin-bound peptides: advantages in competition for antigen presentation.
T cells recognize peptides in association with major histocompatibility complex (MHC) molecules on the surface of antigen-presenting cells (APC). To sensitize APC for antigen presentation in vitro and in vivo, high concentrations of synthetic peptides can be added from the outside and bind to the MHC molecules, thereby mimicking naturally processed peptides. In this report we investigated whether the transferrin (Tf) molecule could be used as a carrier to introduce antigenic peptides into the antigen presentation pathway of APC. We coupled to Tf various MHC class II DR1 restricted peptides and compared the sensitization of DR1+ APC by the Tf-bound or by the soluble peptide, using peptide-specific T cell clones (TCC). The presentation of the Tf-bound peptides was MHC restricted and could be blocked by the fixation of the APC with glutaraldehyde or by the addition of an excess of Tf. Tf-bound peptides were more efficiently presented than soluble peptides, since smaller concentrations were required to sensitize APC. Moreover, they could compete with a soluble peptide for MHC restricted presentation with a very high efficiency if compared to soluble competing peptides. Tf peptide conjugates could even compete with the presentation of a native antigen like tetanus toxoid. Peptides bound to the transferrin molecule might be useful for immunization strategies, as the relevant bound peptides are efficiently presented to peptide-specific TCC.
Mauri
D
D
Institute of Immunology and Allergology, Inselspital, Bern, Switzerland.
Wyss-Coray
T
T
Brander
C
C
Pichler
W J
WJ
D017951:Antigen Presentation; D001667:Binding, Competitive; D002461:Cell Line, Transformed; D002999:Clone Cells; D015798:HLA-DR1 Antigen / Q000276:immunology; D000922:Immunotoxins / Q000276:immunology; D010455:Peptides / Q000276:immunology*; D014677:Pharmaceutical Vehicles; D013601:T-Lymphocytes / Q000276:immunology*; D013745:Tetanus Toxoid; D014168:Transferrin
D015798:HLA-DR1 Antigen; D000922:Immunotoxins; D010455:Peptides; D014677:Pharmaceutical Vehicles; D013745:Tetanus Toxoid; D014168:Transferrin